Jannet C. Beukema
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jannet C. Beukema has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Johannes Albertus Langendijk
Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
6 shared publications Christina T. Muijs
Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
4 shared publicationsJohannes A. Langendijk
Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
3 shared publications- Peter van Luijk
Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
3 shared publications - Christina T. Muijs
University of Groningen, University Medical Center Groningen, Department of Radiation Oncology, Groningen, the Netherlands
2 shared publications - John Th. M. Plukker
Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2 shared publications
Latest Publications
- 8 January 2025
- Published by University of Groningen Press
The relevance of cardiac toxicity in radiotherapy for esophageal cancer
- 8 January 2025
- Published by University of Groningen Press
The relevance of cardiac toxicity in radiotherapy for esophageal cancer
- Open Access
- 14 December 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 203, 110683
Cost-effectiveness of a nurse-led sexual rehabilitation intervention for women treated with radiotherapy for gynaecological cancer in a randomized trial
- 14 December 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 203, 110683
Open AccessCost-effectiveness of a nurse-led sexual rehabilitation intervention for women treated with radiotherapy for gynaecological cancer in a randomized trial
- Open Access
- 18 August 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 200, 110479
Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: A prospective cohort study
- 18 August 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 200, 110479
Open AccessBlood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: A prospective cohort study
- Open Access
- 1 February 2022
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 167, 72-77
Late cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study
- 1 February 2022
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 167, 72-77
Open AccessLate cardiac toxicity of neo-adjuvant chemoradiation in esophageal cancer survivors: A prospective cross-sectional pilot study
- Open Access
- 1 January 2021
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 154, 194-200
Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer
- 1 January 2021
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 154, 194-200
Open AccessInter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer
- Open Access
- 1 August 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 149, 222-227
Can we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients?
- 1 August 2020
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 149, 222-227
Open AccessCan we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients?
- 1 July 2015
- Published by Taylor & Francis in Future Cardiology
- Vol. 11 (4) , 367-369
Cardiac Toxicity in the Radiation Treatment of Esophageal Cancer: an Emerging Concern
- 1 July 2015
- Published by Taylor & Francis in Future Cardiology
- Vol. 11 (4) , 367-369
Cardiac Toxicity in the Radiation Treatment of Esophageal Cancer: an Emerging Concern
- 1 January 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 114 (1) , 85-90
Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?
- 1 January 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 114 (1) , 85-90
Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?
- 1 November 2014
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 113 (2) , 188-192
Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer
- 1 November 2014
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 113 (2) , 188-192
Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer
- Open Access
- 31 March 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106 (3) , 283-287
Oesophageal tumour progression between the diagnostic 18F-FDG-PET and the 18F-FDG-PET for radiotherapy treatment planning
- 31 March 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106 (3) , 283-287
Open AccessOesophageal tumour progression between the diagnostic 18F-FDG-PET and the 18F-FDG-PET for radiotherapy treatment planning